182 related articles for article (PubMed ID: 31268403)
21. Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study.
Parrilla-Reverter G; Agudo M; Sobrado-Calvo P; Salinas-Navarro M; Villegas-Pérez MP; Vidal-Sanz M
Exp Eye Res; 2009 Jun; 89(1):32-41. PubMed ID: 19268467
[TBL] [Abstract][Full Text] [Related]
22. Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma.
Pirhan D; Yüksel N; Emre E; Cengiz A; Kürşat Yıldız D
Curr Eye Res; 2016; 41(1):59-69. PubMed ID: 25658983
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
[TBL] [Abstract][Full Text] [Related]
24. The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection.
Yamamoto K; Sato K; Yukita M; Yasuda M; Omodaka K; Ryu M; Fujita K; Nishiguchi KM; Machida S; Nakazawa T
J Neurochem; 2017 Feb; 140(3):495-508. PubMed ID: 27859240
[TBL] [Abstract][Full Text] [Related]
25. Lycium barbarum (wolfberry) reduces secondary degeneration and oxidative stress, and inhibits JNK pathway in retina after partial optic nerve transection.
Li H; Liang Y; Chiu K; Yuan Q; Lin B; Chang RC; So KF
PLoS One; 2013; 8(7):e68881. PubMed ID: 23894366
[TBL] [Abstract][Full Text] [Related]
26. Roots of Lithospermum erythrorhizon promotes retinal cell survival in optic nerve crush-induced retinal degeneration.
Kang TK; Le TT; Kim KA; Kim YJ; Lee WB; Jung SH
Exp Eye Res; 2021 Feb; 203():108419. PubMed ID: 33383026
[TBL] [Abstract][Full Text] [Related]
27. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration.
Yoles E; Wheeler LA; Schwartz M
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotective effect of memantine in different retinal injury models in rats.
WoldeMussie E; Yoles E; Schwartz M; Ruiz G; Wheeler LA
J Glaucoma; 2002 Dec; 11(6):474-80. PubMed ID: 12483089
[TBL] [Abstract][Full Text] [Related]
29. Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection.
Levkovitch-Verbin H; Kalev-Landoy M; Habot-Wilner Z; Melamed S
Arch Ophthalmol; 2006 Apr; 124(4):520-6. PubMed ID: 16606878
[TBL] [Abstract][Full Text] [Related]
30. Periocular injection of in situ hydrogels containing Leu-Ile, an inducer for neurotrophic factors, promotes retinal ganglion cell survival after optic nerve injury.
Nakatani M; Shinohara Y; Takii M; Mori H; Asai N; Nishimura S; Furukawa-Hibi Y; Miyamoto Y; Nitta A
Exp Eye Res; 2011 Dec; 93(6):873-9. PubMed ID: 22001716
[TBL] [Abstract][Full Text] [Related]
31. A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat.
Maeda K; Sawada A; Matsubara M; Nakai Y; Hara A; Yamamoto T
Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):851-6. PubMed ID: 14985301
[TBL] [Abstract][Full Text] [Related]
32. RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome.
Grinblat GA; Khan RS; Dine K; Wessel H; Brown L; Shindler KS
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2470-2477. PubMed ID: 29847652
[TBL] [Abstract][Full Text] [Related]
33. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush.
Jehle T; Dimitriu C; Auer S; Knoth R; Vidal-Sanz M; Gozes I; Lagrèze WA
Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1255-63. PubMed ID: 18414890
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of 4-(Phenylsulfanyl)butan-2-one on optic nerve crush model in rats.
Chien JY; Sheu JH; Wen ZH; Tsai RK; Huang SP
Exp Eye Res; 2016 Feb; 143():148-57. PubMed ID: 26472213
[TBL] [Abstract][Full Text] [Related]
35. In vivo effects of single or combined topical neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model.
Kitamura Y; Bikbova G; Baba T; Yamamoto S; Oshitari T
Sci Rep; 2019 Jan; 9(1):101. PubMed ID: 30643179
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor alpha has an early protective effect on retinal ganglion cells after optic nerve crush.
Mac Nair CE; Fernandes KA; Schlamp CL; Libby RT; Nickells RW
J Neuroinflammation; 2014 Nov; 11():194. PubMed ID: 25407441
[TBL] [Abstract][Full Text] [Related]
37. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective Effects of Human Serum Albumin Nanoparticles Loaded With Brimonidine on Retinal Ganglion Cells in Optic Nerve Crush Model.
Kim KE; Jang I; Moon H; Kim YJ; Jeoung JW; Park KH; Kim H
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5641-9. PubMed ID: 26313300
[TBL] [Abstract][Full Text] [Related]
39. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.
Lambiase A; Aloe L; Centofanti M; Parisi V; Báo SN; Mantelli F; Colafrancesco V; Manni GL; Bucci MG; Bonini S; Levi-Montalcini R
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13469-74. PubMed ID: 19805021
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
